Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection

Journal of Molecular and Cellular Cardiology

Volumn 55, Issue 1, 2013, Pages 58-63

  Gong, Dingxu ^a   Zhang, Hao ^a   Hu, Shengshou ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Arrhythmia; Autophagy; Cardiac hypertrophy; Cardiac ischemia and reperfusion; Cardioprotective effects; Mitochondrial aldehyde dehydrogenase 2

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; 4 HYDROXYNONENAL; ADENOSINE A2B RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; ALDEHYDE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N (1,3 BENZODIOXOL 5 YLMETHYL) 2,6 DICHLOROBENZAMIDE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SIRTUIN 3; UNCLASSIFIED DRUG;

AUTOPHAGY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; ENZYME SUBUNIT; HEART ARRHYTHMIA; HEART FAILURE; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INHIBITION KINETICS; ISCHEMIC PRECONDITIONING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ALDEHYDE DEHYDROGENASE; ALDEHYDES; ANIMALS; ARRHYTHMIAS, CARDIAC; AUTOPHAGY; CARDIOMEGALY; ENZYME ACTIVATION; HEART FAILURE; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERMEABILITY;

EID: 84872725111     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.03.017     Document Type: Review

References (83)

1. Baker J.L., Olsen L.W., Sorensen T.I. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007, 357(23):2329-2337.
2. Griffin S.J., Borch-Johnsen K., Davies M.J., Khunti K., Rutten G.E., Sandbaek A., et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011, 378(9786):156-167.
3. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209.
4. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321(5895):1493-1495.
5. Churchill E.N., Disatnik M.H., Mochly-Rosen D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of εPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol 2009, 46(2):278-284.
6. Steinmetz C.G., Xie P., Weiner H., Hurley T.D. Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure 1997, 5(5):701-711.
7. Zhang M., Shah A.M. Role of reactive oxygen species in myocardial remodeling. Curr Heart Fail Rep 2007, 4(1):26-30.
8. Hill B.G., Bhatnagar A. Beyond reactive oxygen species: aldehydes as arbitrators of alarm and adaptation. Circ Res 2009, 105(11):1044-1046.
9. Conklin D., Prough R., Bhatanagar A. Aldehyde metabolism in the cardiovascular system. Mol Biosyst 2007, 3(2):136-150.
10. Benedetti A., Comporti M., Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 1980, 620(2):281-296.
11. Chen J., Henderson G.I., Freeman G.L. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol 2001, 33(11):1919-1927.
12. Fukai M., Hayashi T., Yokota R., Shimamura T., Suzuki T., Taniguchi M., et al. Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radic Biol Med 2005, 38(10):1372-1381.
13. Farout L., Mary J., Vinh J., Szweda L.I., Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys 2006, 453(1):135-142.
14. Lucas D.T., Szweda L.I. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc Natl Acad Sci U S A 1999, 96(12):6689-6693.
15. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 2006, 99(7):692-705.
16. Goedde H.W., Agarwal D.P., Harada S., Meier-Tackmann D., Ruofu D., Bienzle U., et al. Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity. Am J Hum Genet 1983, 35(4):769-772.
17. Seitz H.K., Matsuzaki S., Yokoyama A., Homann N., Vakevainen S., Wang X.D. Alcohol and cancer. Alcohol Clin Exp Res 2001, 25(5 Suppl. ISBRA):137S-143S.
18. Larson H.N., Weiner H., Hurley T.D. Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant. J Biol Chem 2005, 280(34):30550-30556.
19. Larson H.N., Zhou J., Chen Z., Stamler J.S., Weiner H., Hurley T.D. Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487. J Biol Chem 2007, 282(17):12940-12950.
20. Jinsmaa Y., Florang V.R., Rees J.N., Anderson D.G., Strack S., Doorn J.A. Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chem Res Toxicol 2009, 22(5):835-841.
21. Vasiliou V., Nebert D.W. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2005, 2(2):138-143.
22. Petersen D.R., Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004, 37(7):937-945.
23. Wenzel P., Muller J., Zurmeyer S., Schuhmacher S., Schulz E., Oelze M., et al. ALDH-2 deficiency increases cardiovascular oxidative stress-evidence for indirect antioxidative properties. Biochem Biophys Res Commun 2008, 367(1):137-143.
24. Marchitti S.A., Brocker C., Stagos D., Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008, 4(6):697-720.
25. Stewart M.J., Malek K., Crabb D.W. Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J Investig Med 1996, 44(2):42-46.
26. Beretta M., Wolkart G., Schernthaner M., Griesberger M., Neubauer R., Schmidt K., et al. Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2. Circ Res 2012, 110(3):385-393.
27. Perez-Miller S., Younus H., Vanam R., Chen C.H., Mochly-Rosen D., Hurley T.D. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol 2010, 17(2):159-164.
28. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
29. Liu G.S., Thornton J., Van Winkle D.M., Stanley A.W., Olsson R.A., Downey J.M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991, 84(1):350-356.
30. Churchill E.N., Murriel C.L., Chen C.H., Mochly-Rosen D., Szweda L.I. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ Res 2005, 97(1):78-85.
31. Murriel C.L., Churchill E., Inagaki K., Szweda L.I., Mochly-Rosen D. Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 2004, 279(46):47985-47991.
32. Yellon D.M., Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003, 83(4):1113-1151.
33. Chen C.H., Gray M.O., Mochly-Rosen D. Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci U S A 1999, 96(22):12784-12789.
34. Budas G.R., Churchill E.N., Disatnik M.H., Sun L., Mochly-Rosen D. Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res 2010, 88(1):83-92.
35. Budas G.R., Disatnik M.H., Chen C.H., Mochly-Rosen D. Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol 2010, 48(4):757-764.
36. Sack M.N. The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging. J Mol Cell Cardiol 2012, 52(3):520-525.
37. Lu Z., Bourdi M., Li J.H., Aponte A.M., Chen Y., Lombard D.B., et al. SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Rep 2011, 12(8):840-846.
38. Xue L., Xu F., Meng L., Wei S., Wang J., Hao P., et al. Acetylation-dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol-induced eNOS activation. FEBS Lett 2012, 586(2):137-142.
39. Bao J., Scott I., Lu Z., Pang L., Dimond C.C., Gius D., et al. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic Biol Med 2010, 49(7):1230-1237.
40. Milne J.C., Denu J.M. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 2008, 12(1):11-17.
41. Zhang X., Li S.Y., Brown R.A., Ren J. Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress. Alcohol 2004, 32(3):175-186.
42. Romanowicz M., Schmidt J.E., Bostwick J.M., Mrazek D.A., Karpyak V.M. Changes in heart rate variability associated with acute alcohol consumption: current knowledge and implications for practice and research. Alcohol Clin Exp Res 2011, 35(6):1092-1105.
43. Li S.Y., Gilbert S.A., Li Q., Ren J. Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress. J Mol Cell Cardiol 2009, 47(2):247-255.
44. Doser T.A., Turdi S., Thomas D.P., Epstein P.N., Li S.Y., Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009, 119(14):1941-1949.
45. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132(1):27-42.
46. Hill B.G., Haberzettl P., Ahmed Y., Srivastava S., Bhatnagar A. Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochem J 2008, 410(3):525-534.
47. Kolattukudy P.E., Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res 2012, 110(1):174-189.
48. Matsui Y., Kyoi S., Takagi H., Hsu C.P., Hariharan N., Ago T., et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008, 4(4):409-415.
49. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007, 100(6):914-922.
50. Takagi H., Matsui Y., Hirotani S., Sakoda H., Asano T., Sadoshima J. AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy 2007, 3(4):405-407.
51. Baines C.P. The cardiac mitochondrion: nexus of stress. Annu Rev Physiol 2010, 72:61-80.
52. Morin D., Assaly R., Paradis S., Berdeaux A. Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr Med Chem 2009, 16(33):4382-4398.
53. Husainy M.A., Dickenson J.M., Galinanes M. The MPTP Status During Early Reoxygenation is Critical for Cardioprotection. J Surg Res 2010, 174(1):62-72.
54. Hunter D.R., Haworth R.A., Southard J.H. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem 1976, 251(16):5069-5077.
55. Waldmeier P.C., Feldtrauer J.J., Qian T., Lemasters J.J. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol 2002, 62(1):22-29.
56. Halestrap A.P. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 2010, 38(4):841-860.
57. Clarke S.J., McStay G.P., Halestrap A.P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 2002, 277(38):34793-34799.
58. Duchen M.R., McGuinness O., Brown L.A., Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 1993, 27(10):1790-1794.
59. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995, 307(Pt. 1):93-98.
60. + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001, 276(4):2571-2575.
61. Kerr P.M., Suleiman M.S., Halestrap A.P. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol 1999, 276(2 Pt. 2):H496-H502.
62. Li Z.H., Jiang C.R., Xia M.L., Ye H.W., Guan S.D., Gao Q. Activation of mitochondrial aldehyde dehydrogenase 2 and inhibition of mitochondrial permeability transition pore involved in cardioprotection of ethanol postconditioning. Zhejiang Da Xue Xue Bao Yi Xue Ban 2010, 39(6):566-571.
63. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008, 359(5):473-481.
64. Shanmuganathan S., Hausenloy D.J., Duchen M.R., Yellon D.M. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005, 289(1):H237-H242.
65. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 1996, 271(11):6033-6038.
66. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434(7033):658-662.
67. Halestrap A. Biochemistry: a pore way to die. Nature 2005, 434(7033):578-579.
68. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434(7033):652-658.
69. Eaton P., Li J.M., Hearse D.J., Shattock M.J. Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol 1999, 276(3 Pt. 2):H935-H943.
70. Ferreira R. The reduction of infarct size-forty years of research. Rev Port Cardiol 2010, 29(6):1037-1053.
71. Condouris G.A., Havelin D.M. Acetaldehyde and cardiac arrhythmias. Arch Int Pharmacodyn Ther 1987, 285(1):50-59.
72. Riveros-Rosas H., Julian-Sanchez A., Pina E. Enzymology of ethanol and acetaldehyde metabolism in mammals. Arch Med Res 1997, 28(4):453-471.
73. Galagudza M., Kurapeev D., Minasian S., Valen G., Vaage J. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardiothorac Surg 2004, 25(6):1006-1010.
74. Na H.S., Kim Y.I., Yoon Y.W., Han H.C., Nahm S.H., Hong S.K. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J 1996, 132(1 Pt. 1):78-83.
75. Petrishchev N.N., Vlasov T.D., Galagudza M.M., Kurapeev D.I., Minasian S.M. Myocardial ischemic postconditioning: a brief ischemia causes conversion of resistent reperfusion-induced ventricular fibrillation into the normal rhythm. Ross Fiziol Zh Im I M Sechenova 2004, 90(9):1138-1144.
76. Vinten-Johansen J., Zhao Z.Q., Jiang R., Zatta A.J., Dobson G.P. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol 2007, 103(4):1441-1448.
77. Cerbai E., Ambrosio G., Porciatti F., Chiariello M., Giotti A., Mugelli A. Cellular electrophysiological basis for oxygen radical-induced arrhythmias. A patch-clamp study in guinea pig ventricular myocytes. Circulation 1991, 84(4):1773-1782.
78. Koda K., Salazar-Rodriguez M., Corti F., Chan N.Y., Estephan R., Silver R.B., et al. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 2010, 122(8):771-781.
79. Kawano T., Matsuse H., Kondo Y., Machida I., Saeki S., Tomari S., et al. Acetaldehyde induces histamine release from human airway mast cells to cause bronchoconstriction. Int Arch Allergy Immunol 2004, 134(3):233-239.
80. Morrey C., Brazin J., Seyedi N., Corti F., Silver R.B., Levi R. Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction. J Pharmacol Exp Ther 2010, 335(1):76-84.
81. Enomoto N., Takase S., Yasuhara M., Takada A. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 1991, 15(1):141-144.
82. Li Y., Zhang D., Jin W., Shao C., Yan P., Xu C., et al. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest 2006, 116(2):506-511.
83. Daiber A., Oelze M., Coldewey M., Bachschmid M., Wenzel P., Sydow K., et al. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 2004, 66(6):1372-1382.